Ramadan is the ninth month of the Islamic calendar. It is a month of fasting, prayer, giving and self-evaluation observed by Muslims. The month lasts 29-30 days depending on the sightings of the crescent moon. Ramadan 2021 begins on April 13, 2021 and will end on May 12, 2021.
Estimates suggest that there are over 150 million Muslims with diabetes worldwide, with the global prevalence continuing to increase. Fasting during Ramadan has a major impact on the management of diabetes in the Muslim population. Since diabetes is a metabolic condition, changes in food and liquid intake can lead to complications including low or high blood glucose levels, dehydration or diabetic ketoacidosis (in people with type 1 diabetes).
For people with diabetes it is recommended to visit a health care professional before Ramadan, to understand the risk that can occur by fasting. Health care professionals are advised to focus on patient education.
Regular blood glucose monitoring is the key to successfully manage diabetes while fasting. Since changes in eating habits during Ramadan affect blood glucose levels, it is important to check blood glucose levels regularly.
DiaSys provides high-quality, ready-to-use reagents for clinical chemistry analyzers, as well as Point-of-Care system for Diabetes management:
Glucose/Hemoglobin IS
Glucose Gluc-DH FS
Glucose GOD FS 5'
Glucose GOD FS 10'
Glucose Hexokinase FS
oneHbA1c IS
oneHbA1c FS
HbA1c net FS
The IDF (International Diabetes Federation) provides a practical guideline for people with Diabetes, as well as health care professionals: https://www.idf.org/our-activities/education/diabetes-and-ramadan.html
Isabella Wieland